PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RMD vs. SYK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RMD and SYK is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

RMD vs. SYK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ResMed Inc. (RMD) and Stryker Corporation (SYK). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%AugustSeptemberOctoberNovemberDecember2025
14.99%
11.79%
RMD
SYK

Key characteristics

Sharpe Ratio

RMD:

0.96

SYK:

1.00

Sortino Ratio

RMD:

1.63

SYK:

1.52

Omega Ratio

RMD:

1.23

SYK:

1.19

Calmar Ratio

RMD:

0.85

SYK:

1.61

Martin Ratio

RMD:

6.00

SYK:

3.97

Ulcer Index

RMD:

5.91%

SYK:

4.76%

Daily Std Dev

RMD:

37.08%

SYK:

18.83%

Max Drawdown

RMD:

-61.60%

SYK:

-58.63%

Current Drawdown

RMD:

-19.26%

SYK:

-5.78%

Fundamentals

Market Cap

RMD:

$34.26B

SYK:

$140.52B

EPS

RMD:

$7.54

SYK:

$9.33

PE Ratio

RMD:

30.95

SYK:

39.51

PEG Ratio

RMD:

1.74

SYK:

2.53

Total Revenue (TTM)

RMD:

$3.64B

SYK:

$16.16B

Gross Profit (TTM)

RMD:

$2.10B

SYK:

$10.03B

EBITDA (TTM)

RMD:

$1.29B

SYK:

$3.89B

Returns By Period

In the year-to-date period, RMD achieves a 2.05% return, which is significantly lower than SYK's 2.38% return. Both investments have delivered pretty close results over the past 10 years, with RMD having a 15.94% annualized return and SYK not far ahead at 16.24%.


RMD

YTD

2.05%

1M

-3.17%

6M

13.84%

1Y

38.39%

5Y*

8.72%

10Y*

15.94%

SYK

YTD

2.38%

1M

-0.87%

6M

10.65%

1Y

18.37%

5Y*

12.96%

10Y*

16.24%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RMD vs. SYK — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RMD
The Risk-Adjusted Performance Rank of RMD is 7979
Overall Rank
The Sharpe Ratio Rank of RMD is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of RMD is 7676
Sortino Ratio Rank
The Omega Ratio Rank of RMD is 7777
Omega Ratio Rank
The Calmar Ratio Rank of RMD is 7878
Calmar Ratio Rank
The Martin Ratio Rank of RMD is 8585
Martin Ratio Rank

SYK
The Risk-Adjusted Performance Rank of SYK is 7878
Overall Rank
The Sharpe Ratio Rank of SYK is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of SYK is 7373
Sortino Ratio Rank
The Omega Ratio Rank of SYK is 7171
Omega Ratio Rank
The Calmar Ratio Rank of SYK is 8888
Calmar Ratio Rank
The Martin Ratio Rank of SYK is 7979
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RMD vs. SYK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and Stryker Corporation (SYK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RMD, currently valued at 0.96, compared to the broader market-2.000.002.000.961.00
The chart of Sortino ratio for RMD, currently valued at 1.63, compared to the broader market-4.00-2.000.002.004.001.631.52
The chart of Omega ratio for RMD, currently valued at 1.23, compared to the broader market0.501.001.502.001.231.19
The chart of Calmar ratio for RMD, currently valued at 0.85, compared to the broader market0.002.004.006.000.851.61
The chart of Martin ratio for RMD, currently valued at 6.00, compared to the broader market-30.00-20.00-10.000.0010.0020.006.003.97
RMD
SYK

The current RMD Sharpe Ratio is 0.96, which is comparable to the SYK Sharpe Ratio of 1.00. The chart below compares the historical Sharpe Ratios of RMD and SYK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00AugustSeptemberOctoberNovemberDecember2025
0.96
1.00
RMD
SYK

Dividends

RMD vs. SYK - Dividend Comparison

RMD's dividend yield for the trailing twelve months is around 0.87%, less than SYK's 0.88% yield.


TTM20242023202220212020201920182017201620152014
RMD
ResMed Inc.
0.87%0.88%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%1.89%
SYK
Stryker Corporation
0.88%0.90%1.02%1.16%0.97%0.96%1.02%1.23%1.13%1.31%1.52%1.34%

Drawdowns

RMD vs. SYK - Drawdown Comparison

The maximum RMD drawdown since its inception was -61.60%, which is greater than SYK's maximum drawdown of -58.63%. Use the drawdown chart below to compare losses from any high point for RMD and SYK. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-19.26%
-5.78%
RMD
SYK

Volatility

RMD vs. SYK - Volatility Comparison

ResMed Inc. (RMD) has a higher volatility of 7.91% compared to Stryker Corporation (SYK) at 5.95%. This indicates that RMD's price experiences larger fluctuations and is considered to be riskier than SYK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%16.00%AugustSeptemberOctoberNovemberDecember2025
7.91%
5.95%
RMD
SYK

Financials

RMD vs. SYK - Financials Comparison

This section allows you to compare key financial metrics between ResMed Inc. and Stryker Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab